Organigram price target lowered to C$3.15 from C$3.60 at Canaccord

Canaccord lowered the firm’s price target on Organigram (OGI) to C$3.15 from C$3.60 and keeps a Speculative Buy rating on the shares following the company’s acquisition of Motif Labs for C$90M. The firm feels the acquisition rounds out Organigram’s product portfolio by “enhancing its overall product portfolio with market-leading brands.”